{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-060675","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2022-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.993876+00:00","generated_at":"2026-06-23T06:16:17.016077+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"China Pharma (CPHI) gets NYSE American deficiency notice; avg price below $0.20, must cure by March 2023","bullets":["Average stock price below $0.20 over 30 days as of Sept 22, 2022 triggers continued listing noncompliance.","NYSE American requires reverse stock split or sustained price improvement by March 26, 2023 to maintain listing.","Company also subject to prior stockholders' equity noncompliance letter from June 2022.","Stock continues trading on NYSE American while company pursues compliance measures."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-060675","json":"https://secwatch.observer/filing/0001213900-22-060675.json","markdown":"https://secwatch.observer/filing/0001213900-22-060675.md","text":"https://secwatch.observer/filing/0001213900-22-060675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390022060675/0001213900-22-060675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390022060675/ea166544-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:16:17.016077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}